Camac Capital, Llc - Net Worth and Insider Trading
Camac Capital, Llc Net Worth
The estimated net worth of Camac Capital, Llc is at least $21 Million dollars as of 2025-04-14. Camac Capital, Llc is the 10% Owner of Gold Reserve Ltd and owns about 10,589,030 shares of Gold Reserve Ltd (GDRZF) stock worth over $21 Million. Details can be seen in Camac Capital, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Camac Capital, Llc has not made any transactions after 2025-04-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Camac Capital, Llc
Camac Capital, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Camac Capital, Llc owns 1 companies in total, including Pasithea Therapeutics Corp (KTTA) .
Click here to see the complete history of Camac Capital, Llc’s form 4 insider trades.
Insider Ownership Summary of Camac Capital, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp | 2022-08-29 | other: Member of 10% owner group |
Camac Capital, Llc Latest Holdings Summary
Camac Capital, Llc currently owns a total of 1 stock. Camac Capital, Llc owns 10,589,030 shares of Gold Reserve Ltd (GDRZF) as of April 7, 2025, with a value of $21 Million.
Latest Holdings of Camac Capital, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GDRZF | Gold Reserve Ltd | 2025-04-07 | 10,589,030 | 1.95 | 20,648,609 |
Holding Weightings of Camac Capital, Llc
Camac Capital, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Camac Capital, Llc has made a total of 7 transactions in Gold Reserve Ltd (GDRZF) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Gold Reserve Ltd is the acquisition of 32,475 shares on April 7, 2025, which cost Camac Capital, Llc around $54,233.
Insider Trading History of Camac Capital, Llc
- 1
Camac Capital, Llc Trading Performance
GuruFocus tracks the stock performance after each of Camac Capital, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Camac Capital, Llc is %. GuruFocus also compares Camac Capital, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Camac Capital, Llc within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Camac Capital, Llc's insider trading performs compared to the benchmark.
Performance of Camac Capital, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.13 |  | | | | |
| Relative Return to S&P 500(%) | 7.77 | | | | | |
Camac Capital, Llc Ownership Network
Ownership Network List of Camac Capital, Llc
Ownership Network Relation of Camac Capital, Llc
Camac Capital, Llc Owned Company Details
What does Pasithea Therapeutics Corp do?
Who are the key executives at Pasithea Therapeutics Corp?
Camac Capital, Llc is the other: Member of 10% owner group of Pasithea Therapeutics Corp. Other key executives at Pasithea Therapeutics Corp include Chief Development Officer Graeme Martin Currie , 10 percent owner Paul B Manning , and 10 percent owner Bradford Manning .
Pasithea Therapeutics Corp (KTTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pasithea Therapeutics Corp (KTTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pasithea Therapeutics Corp (KTTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pasithea Therapeutics Corp (KTTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pasithea Therapeutics Corp Insider Transactions
Camac Capital, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Camac Capital, Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Camac Capital, Llc's mailing address is: New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
